Sanyal AJ - Search Results

1

Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.

Guo C, Liu W, Liu Z, Cai J, Yu X, Wang H, Li X, Zuo D, Jiang X, Zhang B, Liu J, Sanyal AJ, Puri P, Zhou H, Wang XY. Guo C, et al. Among authors: sanyal aj. Hepatology. 2023 Jul 1;78(1):45-57. doi: 10.1097/HEP.0000000000000044. Epub 2023 Jan 13. Hepatology. 2023. PMID: 36632993

2

Modified-orientation log to assess hepatic encephalopathy.

Salam M, Matherly S, Farooq IS, Stravitz RT, Sterling RK, Sanyal AJ, Gibson DP, Wade JB, Thacker LR, Heuman DM, Fuchs M, Puri P, Luketic V, Bickston SJ, Bajaj JS. Salam M, et al. Among authors: sanyal aj. Aliment Pharmacol Ther. 2012 Apr;35(8):913-20. doi: 10.1111/j.1365-2036.2012.05038.x. Epub 2012 Feb 21. Aliment Pharmacol Ther. 2012. PMID: 22348593 Free PMC article.

3

Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.

Cazanave SC, Wang X, Zhou H, Rahmani M, Grant S, Durrant DE, Klaassen CD, Yamamoto M, Sanyal AJ. Cazanave SC, et al. Among authors: sanyal aj. Cell Death Differ. 2014 Aug;21(8):1303-12. doi: 10.1038/cdd.2014.49. Epub 2014 Apr 25. Cell Death Differ. 2014. PMID: 24769730 Free PMC article.

4

Neutrophils exacerbate acetaminophen-induced liver injury by producing cytotoxic interferon-γ.

Wu H, Guo C, Liu Z, Cai J, Wang C, Yi H, Sanyal A, Puri P, Zhou H, Wang XY. Wu H, et al. Int Immunopharmacol. 2023 Oct;123:110734. doi: 10.1016/j.intimp.2023.110734. Epub 2023 Aug 2. Int Immunopharmacol. 2023. PMID: 37541108

5

TIPS: the new kid on the block.

Sanyal AJ. Sanyal AJ. Hepatology. 1994 Oct;20(4 Pt 1):1092-5. Hepatology. 1994. PMID: 7927213 No abstract available.

6

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Sanyal AJ, et al. Hepatology. 1994 Jul;20(1 Pt 1):46-55. doi: 10.1016/0270-9139(94)90133-3. Hepatology. 1994. PMID: 8020904 Clinical Trial.

7

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.

Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP 3rd, Contos MJ, Mills AS, Edinboro LE, Poklis A. Shiffman ML, et al. Among authors: sanyal aj. Hepatology. 1994 Apr;19(4):933-40. Hepatology. 1994. PMID: 8138268

8

The hematologic consequences of transjugular intrahepatic portosystemic shunts.

Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. Sanyal AJ, et al. Hepatology. 1996 Jan;23(1):32-9. doi: 10.1002/hep.510230105. Hepatology. 1996. PMID: 8550045

9

Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Mills AS. Shiffman ML, et al. Among authors: sanyal aj. Hepatology. 1996 Jul;24(1):21-6. doi: 10.1002/hep.510240105. Hepatology. 1996. PMID: 8707264 Clinical Trial.

10

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, Luketic VA, Sanyal AJ, Mills AS, Garrett CT. Shiffman ML, et al. Among authors: sanyal aj. Hepatology. 1997 Sep;26(3):780-5. doi: 10.1002/hep.510260335. Hepatology. 1997. PMID: 9303513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

678 results

Search Page